Luptakova Katarina 4
4 · Xilio Therapeutics, Inc. · Filed Sep 7, 2023
Insider Transaction Report
Form 4
Luptakova Katarina
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2023-09-05+106,000→ 106,000 totalExercise: $2.79Exp: 2033-09-04→ Common Stock (106,000 underlying)
Footnotes (1)
- [F1]The option was granted on September 5, 2023 and will vest in equal monthly installments beginning on October 1, 2023 through September 1, 2027.